These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6896016)
1. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR. Wirth PJ; Alewood P; Calder I; Thorgeirsson SS Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016 [TBL] [Abstract][Full Text] [Related]
2. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells. Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396 [TBL] [Abstract][Full Text] [Related]
3. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine. Camus AM; Friesen M; Croisy A; Bartsch H Cancer Res; 1982 Aug; 42(8):3201-8. PubMed ID: 7046920 [TBL] [Abstract][Full Text] [Related]
4. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene. Beranek DT; White GL; Heflich RH; Beland FA Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940 [TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of the phenacetin metabolites: N-hydroxy-p-phenetidine and nitrosophenetol in S. typhimurium TA100 and derivatives deficient in nitroreductase or O-acetylase: probes for testing intrabacterial metabolic activation. McCoy EC; Rosenkranz HS; Bartsch H Mutat Res; 1986 Apr; 173(4):245-50. PubMed ID: 3513003 [TBL] [Abstract][Full Text] [Related]
6. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system. Holme JA; Haug LT; Dybing E Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin by guinea pig liver microsomal enzymes. Vaught JB; Glowinski IB; King CM Carcinogenesis; 1985 Apr; 6(4):495-9. PubMed ID: 2859126 [TBL] [Abstract][Full Text] [Related]
8. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells. Glatt H; Oesch F Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of species differences in N-hydroxyphenacetin mutagenicity: the role of deacetylation by rat and hamster liver microsomes. Nohmi T; Yoshikawa K; Ishidate M; Hiratsuka A; Watabe T Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4525-31. PubMed ID: 6398128 [No Abstract] [Full Text] [Related]
10. A simple high-pressure liquid chromatographic assay for the N-hydroxy derivatives of phenacetin, acetaminophen, 2-acetylaminofluorene, and other hydroxamic acids. Hinson JA; Pohl LR; Gillette JR Anal Biochem; 1980 Jan; 101(2):462-7. PubMed ID: 7362041 [No Abstract] [Full Text] [Related]
11. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation. Allaben WT; Weeks CE; Weis CC; Burger GT; King CM Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters. Nohmi T; Mizokami K; Kawano S; Fukuhara M; Ishidate M Jpn J Cancer Res; 1987 Feb; 78(2):153-61. PubMed ID: 3104258 [TBL] [Abstract][Full Text] [Related]
13. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide. Hinson JA; Andrews LS; Gillette JR Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868 [No Abstract] [Full Text] [Related]
14. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene. Holme JA; Søderlund EJ Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756 [TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations. Kurelec B; Krca S Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481 [TBL] [Abstract][Full Text] [Related]
16. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system. El-Torkey NM; Weisburger EK Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083 [TBL] [Abstract][Full Text] [Related]
17. Mutagenicity testing in Salmonella typhimurium strains possessing both the His reversion and Ara forward mutation systems and different levels of classical nitroreductase or O-acetyltransferase activities. Jurado J; Alejandre-Durán E; Pueyo C Environ Mol Mutagen; 1994; 23(4):286-93. PubMed ID: 8013475 [TBL] [Abstract][Full Text] [Related]
18. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation. Stout DL; Baptist JN; Matney TS; Shaw CR Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes. Razzouk C; Batardy-Grégoire M; Roberfroid M Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306 [TBL] [Abstract][Full Text] [Related]
20. Effect of ascorbic acid on in vitro mutagenicity and in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in the rat. Thorgeirsson SS; Sakai S; Wirth PJ Mutat Res; 1980 May; 70(3):395-8. PubMed ID: 6155610 [No Abstract] [Full Text] [Related] [Next] [New Search]